Mn. Dworzak et al., Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: Signs of subset expansion and stimulation, J ALLERG CL, 103(5), 1999, pp. 901-906
Background: Skin-associated T cells are defined by the cutaneous lymphocyte
-associated antigen (CLA), In atopic dermatitis (AD), CLA(+) T cells harbor
allergen-reactive memory cells, spontaneously secrete T,, cytokines, and d
isplay signs of increased in vivo activation, thus relating the subset to t
he central disease pathomechanisms.
Objectives: It is not known whether the proportion of circulating CLA(+) T
cells might be expanded in AD. We were therefore prompted to compare the pe
ripheral blood lymphocyte subpopulations of patients with AD with those of
control subjects.
Methods: We used 3-color flow cytometry to investigate age-matched peripher
al blood samples of pediatric and young adult patients with mild (n = 21) o
r severe (n = 15) AD, patients with allergic/atopic diseases not involving
the skin (n = 9), and healthy control subjects (n = 14),
Results: We found no differences among the study groups with respect to the
general proportions of T cells, CD4(+) T cells, CD8(+) T cells, B cells, N
K cells, CD103(+) T cells, and CD25(+) T cells among total circulating lymp
hocytes. However, there were slightly more CD4(+) memory cells and clearly
more HLA-DR+ T cells in patients with severe AD. Most remarkably, patients
with severe AD had a significantly expanded proportion of CLA+ T cells (P =
.024) and CLA(+)/CD4(+) T cells (P = .006) but similar proportions of CLA(
+)/CD8(+) T cells compared with control subjects. Patients with severe AD a
lso had distinctly more HLA-DR+/CLA(+) T cells than control subjects (P = .
005). Similar alterations were seen in patients with mild AD, but these mer
e not statistically significant. After correction for age, all differences
were significant only in probands less than 10 years of age.
Conclusion: Circulating skin-associated T cells (CLA(+)) show signs of subs
et expansion and enhanced activation in patients with AD. These alterations
, compared with control values, affect CD4(+) memory T cells in particular
and are prominent only in children less than 10 years of age.